within Pharmacolibrary.Drugs.ATC.H;

model H04AA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.000225,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00011999999999999999,
    k12             = 7.5,
    k21             = 7.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>H04AA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Glucagon is a peptide hormone produced by the alpha cells of the pancreas. It raises blood glucose levels by promoting glycogen breakdown and gluconeogenesis in the liver. It is mainly used as an emergency treatment for severe hypoglycemia and as a diagnostic aid in radiological examinations. Glucagon is approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Teigen, IA, et al., &amp; Christiansen, SC (2022). Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model. <i>Basic &amp; clinical pharmacology &amp; toxicology</i> 130(6) 623–631. DOI:<a href=&quot;https://doi.org/10.1111/bcpt.13731&quot;>10.1111/bcpt.13731</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35416407/&quot;>https://pubmed.ncbi.nlm.nih.gov/35416407</a></p></li><li><p>Overgaard, RV, et al., &amp; Kildemoes, RJ (2021). Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials. <i>Clinical pharmacokinetics</i> 60(10) 1335–1348. DOI:<a href=&quot;https://doi.org/10.1007/s40262-021-01025-x&quot;>10.1007/s40262-021-01025-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33969456/&quot;>https://pubmed.ncbi.nlm.nih.gov/33969456</a></p></li><li><p>Lee, TS, et al., &amp; Shin, S (2023). Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 1221 123688–None. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2023.123688&quot;>10.1016/j.jchromb.2023.123688</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36989942/&quot;>https://pubmed.ncbi.nlm.nih.gov/36989942</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end H04AA01;
